Hidetoshi Satoh

522 total citations
18 papers, 424 citations indexed

About

Hidetoshi Satoh is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hidetoshi Satoh has authored 18 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Hidetoshi Satoh's work include Cardiovascular Function and Risk Factors (3 papers), Cancer-related Molecular Pathways (3 papers) and Viral Infections and Immunology Research (2 papers). Hidetoshi Satoh is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Cancer-related Molecular Pathways (3 papers) and Viral Infections and Immunology Research (2 papers). Hidetoshi Satoh collaborates with scholars based in Japan and Indonesia. Hidetoshi Satoh's co-authors include Motoyuki Nakamura, Mamoru Satoh, Katsuhiko Hiramori, H Saitoh, Ikuo Segawa, Chihaya Maesawa, Atsushi Tashiro, Tomoyuki Masuda, Tomonari Akatsu and Takayuki Nakajima and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Mayo Clinic Proceedings.

In The Last Decade

Hidetoshi Satoh

16 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetoshi Satoh Japan 9 153 136 95 68 63 18 424
Xiang Ma China 13 207 1.4× 162 1.2× 168 1.8× 36 0.5× 41 0.7× 27 513
Felix Mehrhof Germany 10 303 2.0× 225 1.7× 113 1.2× 53 0.8× 31 0.5× 23 630
Yuki Takazawa Japan 9 84 0.5× 238 1.8× 97 1.0× 52 0.8× 37 0.6× 10 541
Sigrun Badrnya Austria 10 124 0.8× 196 1.4× 93 1.0× 90 1.3× 22 0.3× 16 593
Yoshihiro Sato Japan 14 248 1.6× 107 0.8× 280 2.9× 54 0.8× 61 1.0× 74 714
Koei Yamada Japan 10 83 0.5× 168 1.2× 66 0.7× 46 0.7× 56 0.9× 10 630
Ikuko Nakamura Japan 10 222 1.5× 210 1.5× 106 1.1× 64 0.9× 241 3.8× 19 699
Uwe Haberstroh Germany 7 129 0.8× 159 1.2× 46 0.5× 38 0.6× 83 1.3× 7 475
Arthur M. Magun United States 9 40 0.3× 123 0.9× 77 0.8× 99 1.5× 53 0.8× 14 391
Junyu Huo China 14 96 0.6× 233 1.7× 44 0.5× 87 1.3× 33 0.5× 47 476

Countries citing papers authored by Hidetoshi Satoh

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Satoh more than expected).

Fields of papers citing papers by Hidetoshi Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Satoh. The network helps show where Hidetoshi Satoh may publish in the future.

Co-authorship network of co-authors of Hidetoshi Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Satoh. A scholar is included among the top collaborators of Hidetoshi Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Satoh. Hidetoshi Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morita, Tomoya, S Sekiguchi, Koki Nakamura, et al.. (2024). Amodiaquine Analogs Are Potent Inhibitors of Interleukin-6 Production Induced by Activation of Toll-Like Receptors Recognizing Pathogen Nucleic Acids. Biological and Pharmaceutical Bulletin. 47(12). 2101–2118.
2.
Satoh, Hidetoshi, Yutaka Saga, Yuichi Nishiyama, et al.. (2022). Design, synthesis and biological evaluation of 2-pyrrolone derivatives as radioprotectors. Bioorganic & Medicinal Chemistry. 67. 116764–116764. 1 indexed citations
3.
Morita, Akinori, Hidetoshi Satoh, Yosuke Matsushita, et al.. (2021). A Novel RNA Synthesis Inhibitor, STK160830, Has Negligible DNA-Intercalating Activity for Triggering A p53 Response, and Can Inhibit p53-Dependent Apoptosis. Life. 11(10). 1087–1087. 3 indexed citations
4.
Nishiyama, Yuichi, Akinori Morita, Bing Wang, et al.. (2021). Evaluation of sodium orthovanadate as a radioprotective agent under total-body irradiation and partial-body irradiation conditions in mice. International Journal of Radiation Biology. 97(9). 1241–1251. 6 indexed citations
5.
Morita, Akinori, Kaoru Tanaka, Takanori Katsube, et al.. (2020). Protective Effects of p53 Regulatory Agents Against High-LET Radiation-Induced Injury in Mice. Frontiers in Public Health. 8. 601124–601124. 6 indexed citations
6.
Oyake, Nobuyuki, Toshio Shimada, Yo Murakami, et al.. (2008). Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients. Journal of Nephrology. 21(3). 345–353. 29 indexed citations
7.
Sakata, Koh‐ichi, Nobukazu Fuwa, Takeshi Kodaira, et al.. (2006). Analyses of dose–response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification. Radiotherapy and Oncology. 79(2). 179–184. 27 indexed citations
8.
Oda, Mayuko, et al.. (2006). A proposed mechanism for amitriptyline neurotoxicity based on its detergent nature. Toxicology and Applied Pharmacology. 217(1). 100–106. 23 indexed citations
9.
Miura, Masayoshi, Hiroshi Harada, Daiki Iwami, et al.. (2005). Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation. Clinical Transplantation. 19(s14). 54–58. 8 indexed citations
10.
Satoh, Hidetoshi, Motoyuki Nakamura, Mamoru Satoh, et al.. (2004). Expression and localization of tumour necrosis factor-α and its converting enzyme in human abdominal aortic aneurysm. Clinical Science. 106(3). 301–306. 51 indexed citations
11.
Nishikawa, Shuji, et al.. (2004). [Malignant lymphoma of the pancreas with chronic hepatitis C].. PubMed. 101(11). 1227–31. 3 indexed citations
12.
Nakamura, Motoyuki, Mamoru Satoh, Hidetoshi Satoh, et al.. (2002). Reversible Restrictive Cardiomyopathy Due to Light-Chain Deposition Disease. Mayo Clinic Proceedings. 77(2). 193–196. 16 indexed citations
13.
Nakamura, Motoyuki, Mamoru Satoh, Hidetoshi Satoh, et al.. (2002). Reversible Restrictive Cardiomyopathy Due to Light-Chain Deposition Disease. Mayo Clinic Proceedings. 77(2). 193–196. 17 indexed citations
14.
Satoh, Mamoru, Motoyuki Nakamura, H Saitoh, et al.. (2002). Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clinical Science. 102(4). 381–386. 61 indexed citations
15.
Satoh, Mamoru, Motoyuki Nakamura, Hidetoshi Satoh, et al.. (2000). Expression of tumor necrosis factor-alpha–converting enzyme and tumor necrosis factor-alpha in human myocarditis. Journal of the American College of Cardiology. 36(4). 1288–1294. 56 indexed citations
16.
Satoh, Hidetoshi, et al.. (2000). Advanced e-beam reticle writing system for next-generation reticle fabrication. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4066. 594–594. 1 indexed citations
17.
Satoh, Mamoru, Motoyuki Nakamura, H Saitoh, et al.. (1999). Tumor Necrosis Factor-α–Converting Enzyme and Tumor Necrosis Factor-α in Human Dilated Cardiomyopathy. Circulation. 99(25). 3260–3265. 110 indexed citations
18.
Takahashi, Toru, et al.. (1996). Unilateral Acute Exacerbation of Pulmonary Fibrosis in Association with Sjoegren's Syndrome.. Internal Medicine. 35(10). 811–814. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026